Literature DB >> 27241338

Appendectomy in mid and later life and risk of Parkinson's disease: A population-based study.

Connie Marras1,2, Anthony E Lang1, Peter C Austin3,2, Cindy Lau3, David R Urbach3,4,2.   

Abstract

INTRODUCTION: Pathogenic movement of alpha-synuclein from the gut to the brain in PD has been proposed. The appendix has a relatively high density of alpha-synuclein deposition in neurologically healthy individuals. We investigated the incidence of PD after appendectomy.
METHODS: Using cause-specific hazards regression models, we compared persons over 35 years of age who had undergone appendectomy with two groups of age- and sex-matched individuals having had: (1) a cholecystectomy and (2) neither procedure. Subsequent diagnoses of PD were identified.
RESULTS: Among 42,999 individuals undergoing appendectomy, no difference in risk of PD was identified compared to cholecystectomy (hazard ratio = 1.004; 95% confidence interval: 0.740-1.364). Compared with no procedure, individuals with appendectomy had a higher incidence of PD within 5 years, but no significant difference in risk thereafter.
CONCLUSION: In our study, appendectomy in mid or late life does not appear to be associated with a reduced risk of PD.
© 2016 International Parkinson and Movement Disorder Society. © 2016 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; appendectomy; etiology

Mesh:

Year:  2016        PMID: 27241338     DOI: 10.1002/mds.26670

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  Past appendectomy may be related to early cognitive dysfunction in Parkinson's disease.

Authors:  Alexandra R Gonçalves; Alexandre Mendes; Nuno Vila-Chã; Joana Damásio; Joana Fernandes; Sara M Cavaco
Journal:  Neurol Sci       Date:  2020-06-11       Impact factor: 3.307

2.  Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women.

Authors:  Natalia Palacios; Katherine C Hughes; Emanuele Cereda; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2018-09-14       Impact factor: 10.338

3.  Non-CNS pathogenic origin of Parkinson's disease.

Authors:  Humdoon Choudhry; Lawrence C Perlmuter
Journal:  J Neurol       Date:  2017-08-14       Impact factor: 4.849

Review 4.  Is Parkinson's disease a chronic low-grade inflammatory bowel disease?

Authors:  Malvyne Rolli-Derkinderen; Laurène Leclair-Visonneau; Arnaud Bourreille; Emmanuel Coron; Michel Neunlist; Pascal Derkinderen
Journal:  J Neurol       Date:  2019-04-12       Impact factor: 4.849

Review 5.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

6.  Tonsillectomy and risk of Parkinson's disease: A danish nationwide population-based cohort study.

Authors:  Elisabeth Svensson; Victor W Henderson; Szimonetta Szépligeti; Morten Gersel Stokholm; Tejs Ehlers Klug; Henrik Toft Sørensen; Per Borghammer
Journal:  Mov Disord       Date:  2017-11-29       Impact factor: 10.338

Review 7.  Gastrointestinal dysfunction in the synucleinopathies.

Authors:  Kathryn A Chung; Ronald F Pfeiffer
Journal:  Clin Auton Res       Date:  2020-11-27       Impact factor: 4.435

8.  The vermiform appendix impacts the risk of developing Parkinson's disease.

Authors:  Bryan A Killinger; Zachary Madaj; Jacek W Sikora; Nolwen Rey; Alec J Haas; Yamini Vepa; Daniel Lindqvist; Honglei Chen; Paul M Thomas; Patrik Brundin; Lena Brundin; Viviane Labrie
Journal:  Sci Transl Med       Date:  2018-10-31       Impact factor: 17.956

Review 9.  Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses.

Authors:  Honglei Chen; Keran Wang; Filip Scheperjans; Bryan Killinger
Journal:  Neurobiol Dis       Date:  2021-12-23       Impact factor: 7.046

Review 10.  The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system.

Authors:  Shu-Ying Liu; Piu Chan; A Jon Stoessl
Journal:  Transl Neurodegener       Date:  2017-02-20       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.